CAG
30
4
FLS
73
-2
PPL
54
2
HP
38
-2
DE
46
3
EOG
58
2
EXPE
88
2
AIG
38
-4
ZBH
60
-2
CSCO
63
2
NAVI
41
-3
TGNA
53
2
XOM
47
5
DAL
80
-4
K
53
2
CMCSA
48
2
EQT
59
2
DVA
72
2
BEN
45
3
QRVO
6
2
CAG
30
4
FLS
73
-2
PPL
54
2
HP
38
-2
DE
46
3
EOG
58
2
EXPE
88
2
AIG
38
-4
ZBH
60
-2
CSCO
63
2
NAVI
41
-3
TGNA
53
2
XOM
47
5
DAL
80
-4
K
53
2
CMCSA
48
2
EQT
59
2
DVA
72
2
BEN
45
3
QRVO
6
2
Financhill
Back

Biodexa Pharmaceuticals PLC 10K Form

Sell
20

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
4.36
Seasonality Move:
-24.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BDRX News And Ratings

See the #1 stock for the next 7 days that we like better than BDRX

BDRX Financial Statistics

Sales & Book Value

Annual Sales: $474.09K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $30.44
Price / Book: 0.19

Profitability

EPS (TTM): -74.59720
Net Income (TTM): $-8.53M
Gross Margin: $-4.59M
Return on Equity: 0%
Return on Assets: 0%

Biodexa Pharmaceuticals PLC Earnings Forecast

Key Biodexa Pharmaceuticals PLC Financial Ratios

  • The Gross Profit Margin over the past 11 years for BDRX is -967.45%.
  • The Selling, General & Administrative Expenses for BDRX have been equal to 1,139.63% of Gross Profit Margin.
  • The Interest Expense is -0.58% of Operating Income.
  • The Net Earning history of BDRX is -1,857.99% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 6 years.

Biodexa Pharmaceuticals PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BDRX
Website: biodexapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BDRX Technical Analysis vs Fundamental Analysis

Sell
20
Biodexa Pharmaceuticals PLC (BDRX) is a Sell

Is Biodexa Pharmaceuticals PLC a Buy or a Sell?